Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective

• Published in: Indian journal of dermatology, venereology, and leprology venereology, and leprology, 2016-11, Vol.82 (6), p.603-625
• Main Authors: Gupta, Lalit, Martin, Abhay, Agarwal, Nidheesh, D'Souza, Paschal, Das, Sudip, Kumar, Rajesh, Pande, Sushil, Das, Nilay, Kumaresan, Muthuvel, Kumar, Piyush, Garg, Anubhav, Singh, Saurabh
• Format: Article
• Language: English
• Subjects: Adrenal Cortex Hormones - therapeutic use; Analysis; Antigens; Care and treatment; Committees; Cyclosporine - therapeutic use; Disease Management; Drugs; Gangrene; Health aspects; Humans; Illnesses; Immunoglobulins, Intravenous - therapeutic use; India - epidemiology; Ligands; Medical prognosis; Mortality; Patients; Practice guidelines (Medicine); Practice Guidelines as Topic - standards; Prednisolone - therapeutic use; Prospective Studies; Retrospective Studies; Sepsis; Stevens-Johnson syndrome; Stevens-Johnson Syndrome - diagnosis; Stevens-Johnson Syndrome - epidemiology; Stevens-Johnson Syndrome - therapy; Tumor necrosis factor; Tumor necrosis factor-TNF
• ISSN: 0378-6323; 0973-3922; 1998-3611
• DOI: 10.4103/0378-6323.191134

Background: Stevens-Johnson syndrome and toxic epidermal necrolysis are severe, life-threatening mucocutaneous adverse drug reactions with a high morbidity and mortality that require immediate medical care. The various immunomodulatory treatments include systemic corticosteroids, cyclosporine, intravenous immunoglobulin, cyclophosphamide, plasmapheresis and tumor necrosis factor-α inhibitors. Aim: The ideal therapy of Stevens-Johnson syndrome/toxic epidermal necrolysis still remains a matter of debate as there are only a limited number of studies of good quality comparing the usefulness of different specific treatments. The aim of this article is to comprehensively review the published medical literature and frame management guidelines suitable in the Indian perspective. Methods: The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) assigned the task of preparing these guidelines to its special interest group on cutaneous adverse drug reactions. The group performed a comprehensive English language literature search for management options in Stevens-Johnson syndrome/toxic epidermal necrolysis across multiple databases (PubMed, EMBASE, MEDLINE and Cochrane) for keywords (alone and in combination) and MeSH items such as "guidelines," "Stevens-Johnson syndrome," "toxic epidermal necrolysis," "corticosteroids," "intravenous immunoglobulin," "cyclosporine" and "management." The available evidence was evaluated using the strength of recommendation taxonomy and graded using a three-point scale. A draft of clinical recommendations was developed on the best available evidence which was also scrutinized and critically evaluated by the IADVL Academy of Dermatology. Based on the inputs received, this final consensus statement was prepared. Results: A total of 104 articles (meta-analyses, prospective and retrospective studies, reviews [including chapters in books], previous guidelines [including Indian guidelines of 2006] and case series) were critically evaluated and the evidence thus gathered was used in the preparation of these guidelines. Recommendations: This expert group recommends prompt withdrawal of the culprit drug, meticulous supportive care, and judicious and early (preferably within 72 h) initiation of moderate to high doses of oral or parenteral corticosteroids (prednisolone 1-2 mg/kg/day or equivalent), tapered rapidly within 7-10 days. Cyclosporine (3-5 mg/kg/day) for 10-14 days may also be used either alone, or in combination